Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Stealth Biotherapeutics Corp ADR (MITO)

Stealth Biotherapeutics Corp ADR (MITO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Stealth BioTherapeutics Announces Mito Assist™ Patient Support Program and Specialty Pharmacy Partnership with AnovoRx to Distribute FORZINITY™(elamipretide) injection PR Newswire - Thu Oct 9, 2025

Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community

MITO : 0.3200 (-1.36%)
Stealth BioTherapeutics Corp Announces Completion of Merger PR Newswire - Wed Nov 16, 2022

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) (the "Company" or "Stealth BioTherapeutics"), a clinical-stage biotechnology company focused on the...

MITO : 0.3200 (-1.36%)
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS) PR Newswire - Tue Nov 1, 2022

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq : MITO), a clinical-stage biotechnology company focused on the discovery, development, and...

MITO : 0.3200 (-1.36%)
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders PR Newswire - Fri Oct 7, 2022

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) ("Stealth" or the "Company"), a clinical-stage biotechnology company focused on the discovery,...

MITO : 0.3200 (-1.36%)
Stealth BioTherapeutics Announces Departure of Chief Financial Officer PR Newswire - Fri Sep 30, 2022

/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization...

MITO : 0.3200 (-1.36%)
Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events PR Newswire - Thu Sep 15, 2022

/PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development, and...

MITO : 0.3200 (-1.36%)

Barchart Exclusives

Altria Stock: Why Q2 Matters for Its High-Yield Appeal Barchart - Mon Jul 27, 6:30PM CDT
Altria's Dividend King reputation faces another important test in the upcoming Q2 earnings report as investors look beyond its shrinking cigarette business. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.